We are live on
!
Find out more
Rockefeller Capital Management Portfolio holdings
AUM
$56.4B
1-Year Est. Return
24.96%
This Fund
S&P 500
This Quarter
Est. Return
+16.85%
1 Year Est. Return
+24.96%
3 Year Est. Return
+83.53%
5 Year Est. Return
+100.91%
10 Year Est. Return
–
AUM
$13.2B
AUM Growth
+$2.53B
(+24%)
Cap. Flow
+$1B
Cap. Flow
% of AUM
7.59%
Top 10 Holdings %
Top 10 Hldgs %
23.93%
Holding
3,118
New
401
Increased
1,400
Reduced
617
Closed
168
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$120M |
| 2 |
Globe Life
GL
|
+$115M |
| 3 |
MPT
Medical Properties Trust
MPT
|
+$91.5M |
| 4 |
Arch Capital
ACGL
|
+$69.2M |
| 5 |
Amazon
AMZN
|
+$45.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Progressive
PGR
|
+$138M |
| 2 |
GSK
GSK
|
+$98.7M |
| 3 |
Crown Holdings
CCK
|
+$92.3M |
| 4 |
American Water Works
AWK
|
+$54M |
| 5 |
SolarEdge
SEDG
|
+$45.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.64% |
| 2 | Financials | 15.05% |
| 3 | Healthcare | 13.07% |
| 4 | Consumer Discretionary | 9.61% |
| 5 | Communication Services | 7.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Insulet
PODD
$9.65B
| $41.4M | 0.31% |
162,025
-6,136
| -4% | -$1.52M |
|
|
MASI
77
DELISTED
Masimo
MASI
| $40.4M | 0.31% |
150,575
-16,027
| -10% | -$4M |
|
78
Danaher
DHR
$141B
| $40.1M | 0.3% |
203,645
+32,957
| +19% | +$6.61M |
|
79
Procter & Gamble
PG
$342B
| $39.5M | 0.3% |
283,668
+38,163
| +16% | +$5.33M |
|
80
Thermo Fisher Scientific
TMO
$214B
| $39.4M | 0.3% |
84,528
+20,106
| +31% | +$9.43M |
|
|
TPIC
81
DELISTED
TPI Composites
TPIC
| $38.9M | 0.3% |
737,926
+47,638
| +7% | +$1.9M |
|
82
Chemed
CHE
$7.18B
| $38.4M | 0.29% |
72,073
-9,006
| -11% | -$4.42M |
|
83
Adobe
ADBE
$103B
| $38.4M | 0.29% |
76,702
+10,440
| +16% | +$5.04M |
|
84
Littelfuse
LFUS
$11.7B
| $38.2M | 0.29% |
149,989
-2,510
| -2% | -$556K |
|
85
Merit Medical Systems
MMSI
$5.23B
| $37.4M | 0.28% |
673,262
-94,795
| -12% | -$4.89M |
|
86
Badger Meter
BMI
$3.97B
| $37M | 0.28% |
393,117
+7,864
| +2% | +$628K |
|
87
IPG Photonics
IPGP
$3.69B
| $36.6M | 0.28% |
163,498
-4,307
| -3% | -$863K |
|
88
Vanguard Total World Stock ETF
VT
$79.1B
| $36.5M | 0.28% |
393,985
+48,388
| +14% | +$4.2M |
|
89
Tetra Tech
TTEK
$8.89B
| $35.9M | 0.27% |
1,549,495
+11,415
| +0.7% | +$257K |
|
90
Factset
FDS
$9.77B
| $35.1M | 0.27% |
105,419
-1,356
| -1% | -$448K |
|
91
TSMC
TSM
$2.17T
| $35M | 0.27% |
321,224
+53,672
| +20% | +$5.09M |
|
92
Abbott
ABT
$187B
| $34.7M | 0.26% |
317,220
+50,672
| +19% | +$5.51M |
|
93
Bristol-Myers Squibb
BMY
$131B
| $34.7M | 0.26% |
559,732
+46,468
| +9% | +$2.86M |
|
94
Gentherm
THRM
$1.24B
| $34.7M | 0.26% |
532,002
-3,757
| -0.7% | -$203K |
|
95
Colgate-Palmolive
CL
$74.1B
| $34.6M | 0.26% |
404,398
+28,607
| +8% | +$2.37M |
|
96
Salesforce
CRM
$153B
| $34.4M | 0.26% |
154,694
+22,101
| +17% | +$5.37M |
|
97
United Parcel Service
UPS
$87.7B
| $34.4M | 0.26% |
204,338
+7,876
| +4% | +$1.33M |
|
|
VCRA
98
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $34.2M | 0.26% |
824,402
-13,650
| -2% | -$468K |
|
99
Aaon
AAON
$7.39B
| $33.5M | 0.25% |
754,646
-10,762
| -1% | -$455K |
|
100
Eaton
ETN
$174B
| $33.2M | 0.25% |
276,482
+33,333
| +14% | +$3.77M |
|
Similar funds
NAMI
Rockefeller Capital Management's Q4 2020 Portfolio in Review
As of Q4 2020, Rockefeller Capital Management held 3,118 positions worth $13.2B, up 24% from $10.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Rockefeller Capital Management deployed $1B of net new capital in Q4 2020, opening 401 new positions and adding to 1,400 existing holdings. Its largest new stake was BridgeBio Pharma: 777,031 shares worth $55.3M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Progressive, an estimated $138M trimmed.
- Rockefeller Capital Management's largest Q4 2020 buy was BridgeBio Pharma: 777,031 shares worth $55.3M.
- Rockefeller Capital Management added most to Alibaba in Q4 2020, an estimated $120M increase.
- Rockefeller Capital Management's biggest Q4 2020 reduction was Progressive, cutting an estimated $138M.
- Rockefeller Capital Management fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $1.67M.
- Rockefeller Capital Management's ten largest holdings make up 24% of its $13.2B portfolio in Q4 2020.
- Rockefeller Capital Management opened 401 new positions and closed 168 in Q4 2020.
- Rockefeller Capital Management's portfolio value rose 24% quarter-over-quarter to $13.2B.
Based on Rockefeller Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.